Valuation: Optimax Holdings

Market Cap 274M 67.16M 59.67M 55.69M 50.76M 95.74M 6.46B 96.63M 674M 261M 3.3B 252M 247M 10.59B P/E 2026 *
19.8x
P/E 2027 * 17.4x
Enterprise Value 271M 66.4M 59M 55.06M 50.19M 94.66M 6.38B 95.54M 666M 258M 3.26B 249M 244M 10.47B EV / Sales 2026 *
1.78x
EV / Sales 2027 * 1.69x
Free-Float
23.9%
Yield 2026 *
3.02%
Yield 2027 * 3.42%
09-28 Optimax Launches Specialist Clinic MT
09-28 Optimax Holdings Berhad Expands Beyond Ophthalmology Into Ear, Nose And Throat Specialist Care With Nasenmax Clinic In Damansara Jaya, Selangor CI
09-18 Optimax Holdings Berhad Announces Resignation of Yeng Shi Mei as Company Secretary, Effective September 18, 2026 CI
09-18 Optimax Holdings Berhad Announces Appointment of Chris Tan Song En as Company Secretary, Effective September 18, 2026 CI
08-28 Optimax Holdings Berhad Announces Appointment of Choe Shin Yee as Independent and Non Executive Director, Effective September 1, 2026 CI
08-28 Optimax Holdings Berhad Appoints Choe Shin Yee as Independent and Non Executive Member of Nomination and Remuneration Committee, Effective September 1, 2026 CI
08-28 Optimax Holdings Berhad Appoints Choe Shin Yee as Independent and Non Executive Member of Audit Committee , Effective September 1, 2026 CI
08-19 Optimax Holdings Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-25 Maybank Research Downgrades Optimax Holdings to Hold from Buy; Price Target is MYR0.58 MT
05-22 Optimax Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-03 Optimax to Start Offering ENT Services Following Malaysian Health Ministry's Nod MT
03-02 Optimax Holdings Berhad Receives Approval from Ministry of Health to Offer Otorhinolaryngology (Ear, Nose and Throat) Services CI
02-27 Optimax Holdings Berhad Announces Second Interim Single-Tier Dividend on Ordinary Share, Payable 30 March 2026 CI
1 day-1.94%
1 week-0.98%
1 month-1.94%
3 months-4.72%
6 months-2.88%
Current year-12.17%
1 week 0.5
Extreme 0.495
0.52
1 month 0.5
Extreme 0.495
0.52
Current year 0.5
Extreme 0.495
0.64
1 year 0.5
Extreme 0.495
0.72
3 years 0.46
Extreme 0.46
0.74
5 years 0.46
Extreme 0.46
0.84
10 years 0.3
Extreme 0.305
0.94
Manager TitleAgeSince
Chief Executive Officer 37 01/12/2019
Director of Finance/CFO 38 01/09/2018
Chief Operating Officer 37 01/01/2024
Director TitleAgeSince
Director/Board Member 81 01/12/2021
Chairman 65 01/12/2021
Director/Board Member 70 09/08/2018
Date Insider Type Main position Quantity % Market Cap. Importance
6/3/26 A Buy

Chairman

97,000 0.0179%
5/29/26 A Buy

Chairman

3,000 0.0006%
4/18/25 A
Sena Healthcare Services Sdn. Bhd.
BuyCompany 674,000 0.1241%
Change 5-day change 1-year change 3-year change Capi.($)
-1.94%-0.98%-25.74%-26.28% 67.16M
+1.48%-3.00%+11.63%+24.06% 111B
+0.78%-2.05%0.00%+72.60% 92.38B
+0.46%-0.54%+156.13%+839.45% 59.15B
-0.38%-5.45%-7.18%+53.64% 27.66B
+0.97%-1.27%+28.94%+92.98% 25.75B
+1.28%-0.37%+10.40%+54.59% 25.02B
-0.57%+0.09%-15.78%-7.70% 20.99B
+1.83%-0.42%+27.16%+290.84% 20.82B
+1.30%-2.86%-5.57%+34.95% 16.87B
Average +0.52%-1.75%+18.00%+142.91% 39.93B
Weighted average by Cap. +0.89%-2.05%+28.72%+177.18%

Financials

2026 *2027 *
Net sales 153M 37.36M 33.19M 30.98M 28.24M 53.26M 3.59B 53.75M 375M 145M 1.84B 140M 137M 5.89B 155M 38M 33.76M 31.51M 28.72M 54.17M 3.65B 54.67M 381M 148M 1.87B 143M 140M 5.99B
Net income 13.96M 3.42M 3.04M 2.83M 2.58M 4.87M 329M 4.92M 34.31M 13.29M 168M 12.83M 12.56M 539M 15.74M 3.85M 3.42M 3.19M 2.91M 5.49M 370M 5.54M 38.65M 14.98M 189M 14.46M 14.15M 607M
Net Debt -3.1M -759K -674K -629K -574K -1.08M -72.95M -1.09M -7.62M -2.95M -37.29M -2.85M -2.79M -120M -12.4M -3.04M -2.7M -2.52M -2.29M -4.33M -292M -4.37M -30.46M -11.8M -149M -11.4M -11.15M -479M
Logo Optimax Holdings
Optimax Holdings Berhad is a Malaysia-based investment holding company offering eye specialist services. It has approximately seven satellite clinics/centers, 13 ambulatory care centers, one specialist hospital, and 288 staff/professional doctors. Its geographical segments include North Malaysia, Central Malaysia, South Malaysia, East Malaysia, and Cambodia. Its services are categorized into Refractive Surgery, Treatment of Eye Diseases and Disorders, Consultation and Dispensary Services, Oculoplastic Surgery, Plastic Surgery, and Aesthetic Services. Refractive Surgery includes laser and implant vision correction procedures. Treatment of Eye Diseases and Disorders includes cataract surgery and other medical interventions. Consultation and Dispensary Services cover doctor consultations and medication dispensing. Oculoplastic Surgery provides functional and cosmetic treatments around the eye. Its additional services include Eye Examinations, Sales of Optical Wear, and Laboratory Tests.
Employees
-
Date Price Change Volume
02/10/26 MYR 0.5050 -1.94% 55,900
01/10/26 MYR 0.5150 +1.98% 105,000
30/09/26 MYR 0.5050 +1.00% 781,600
29/09/26 MYR 0.5000 -1.96% 436,300
28/09/26 MYR 0.5100 0.00% 86,200
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.5050MYR
Average target price
0.6125MYR
Spread / Average Target
+21.29%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 0222 Stock